US stock yield curve analysis and recession indicator monitoring to understand broader economic health. Our macro research helps you anticipate market conditions that could impact your investment strategy.
This analysis covers the April 24, 2026 announcement that Bristol Myers Squibb (NYSE: BMY) and co-marketing partner Pfizer (NYSE: PFE) will list their top-selling anticoagulant Eliquis on the Mark Cuban Cost Plus Drug Company (MCCPDC) platform starting the following week, priced at $345 for a 30-day
Bristol Myers Squibb (BMY) - Partners With Pfizer to List Blockbuster Anticoagulant Eliquis on Mark Cuban Cost Plus Platform at $345 Monthly - Special Situation
BMY - Stock Analysis
4184 Comments
789 Likes
1
Shadeen
Active Reader
2 hours ago
I came, I read, I’m confused.
👍 99
Reply
2
Onir
Engaged Reader
5 hours ago
That deserves a parade.
👍 222
Reply
3
Quinncy
Influential Reader
1 day ago
US stock customer concentration analysis and revenue diversification assessment for business risk evaluation and investment safety assessment. We identify companies with too much dependency on single customers or concentrated revenue sources that could pose risks. We provide customer analysis, revenue diversification scoring, and concentration risk assessment for comprehensive coverage. Understand business risks with our comprehensive concentration analysis and diversification tools for safer investing.
👍 22
Reply
4
Gracen
Registered User
1 day ago
Such a creative approach, hats off! 🎩
👍 18
Reply
5
Desheena
Engaged Reader
2 days ago
Free US stock put/call ratio analysis and sentiment contrarian indicators for market timing signals and sentiment assessment. We monitor options market activity to understand when markets might be too bullish or bearish and due for a reversal. We provide put/call ratio analysis, sentiment contrarian signals, and market timing indicators for comprehensive coverage. Time the market with our comprehensive sentiment analysis and contrarian indicators tools for contrarian investing.
👍 262
Reply
© 2026 Market Analysis. All data is for informational purposes only.